57 related articles for article (PubMed ID: 38491829)
1. Carboplatin hypersensitivity reactions.
Winkeljohn D; Polovich M
Clin J Oncol Nurs; 2006 Oct; 10(5):595-8. PubMed ID: 17063613
[TBL] [Abstract][Full Text] [Related]
2. Hypersensitivity Reactions to Platinum Agents and Taxanes.
Tsao LR; Young FD; Otani IM; Castells MC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
[TBL] [Abstract][Full Text] [Related]
3. A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H; Matsumoto K; Morita M; Nagasawa T; Nishio H; Suzuki J; Nishio S; Kobara H; Yunokawa M; Ariyoshi K; Hirayama T; Tokunaga H; Ukita M; Yoriki K; Mori-Uchino M; Furusawa A; Togami S; Nakamura H; Ishikawa M; Satoh T
Cancer Med; 2024 Mar; 13(5):e6968. PubMed ID: 38491829
[TBL] [Abstract][Full Text] [Related]
4. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy.
Shibata N; Kawakami K; Hisanori S; Kobayashi K; Yunokawa M; Kanao H; Taki I; Murase R; Kamei D; Yamaguchi M
Anticancer Res; 2022 Feb; 42(2):1091-1097. PubMed ID: 35093911
[TBL] [Abstract][Full Text] [Related]
6. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
[TBL] [Abstract][Full Text] [Related]
7. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies.
Koshiba H; Hosokawa K; Kubo A; Miyagi Y; Oda T; Miyagi Y; Watanabe A; Honjo H
Int J Gynecol Cancer; 2009 Apr; 19(3):460-5. PubMed ID: 19407575
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Adverse Events of Carboplatin Desensitisation Therapy for Gynaecological Cancer: A Retrospective Study.
Yamamoto A; Kamoi S; Matsuda S; Kawase R; Nakanishi K; Suzuki S
Medicines (Basel); 2022 Mar; 9(4):. PubMed ID: 35447874
[TBL] [Abstract][Full Text] [Related]
10. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
[TBL] [Abstract][Full Text] [Related]
11. 4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.
Nishimura M; Sakai H; Onoe T; Boku S; Yokoyama T; Kadokura G; Morita S; Katsumata N; Matsumoto K
Int J Clin Oncol; 2021 Aug; 26(8):1553-1560. PubMed ID: 34037884
[TBL] [Abstract][Full Text] [Related]
12. World allergy organization anaphylaxis guidance 2020.
Cardona V; Ansotegui IJ; Ebisawa M; El-Gamal Y; Fernandez Rivas M; Fineman S; Geller M; Gonzalez-Estrada A; Greenberger PA; Sanchez Borges M; Senna G; Sheikh A; Tanno LK; Thong BY; Turner PJ; Worm M
World Allergy Organ J; 2020 Oct; 13(10):100472. PubMed ID: 33204386
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
Miller DS; Filiaci VL; Mannel RS; Cohn DE; Matsumoto T; Tewari KS; DiSilvestro P; Pearl ML; Argenta PA; Powell MA; Zweizig SL; Warshal DP; Hanjani P; Carney ME; Huang H; Cella D; Zaino R; Fleming GF
J Clin Oncol; 2020 Nov; 38(33):3841-3850. PubMed ID: 33078978
[TBL] [Abstract][Full Text] [Related]
14. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.
Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM
Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265
[TBL] [Abstract][Full Text] [Related]
15. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.
Altwerger G; Florsheim EB; Menderes G; Black J; Schwab C; Gressel GM; Nelson WK; Carusillo N; Passante T; Huang G; Litkouhi B; Azodi M; Silasi DA; Santin A; Schwartz PE; Ratner ES
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2449-2456. PubMed ID: 30255380
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
